CureChat News
2023-11-02 15:42

CureChat Launches Dana Chatbot

Press Release

FOR IMMEDIATE RELEASE
CureChat Unveils Dana: A Breakthrough AI-Powered Diabetes Management Chatbot
Tel Aviv, Israel - 2-Nov-2023: In a significant leap forward for diabetes care, CureChat is thrilled to announce the launch of Dana, an advanced AI-driven chatbot designed to transform diabetes management. Dana leverages cutting-edge artificial intelligence to provide personalized, 24/7 support for people with diabetes, addressing their unique clinical and emotional needs.
Revolutionizing Diabetes Management with AI
The global diabetes epidemic demands innovative solutions. Dana rises to this challenge by offering a level of personalized care previously unattainable in digital health. Using sophisticated AI algorithms, Dana understands and responds to any diabetes-related question in free text, considering each user's specific health situation and emotional state. This creates a truly tailored and empathetic experience, akin to conversing with a knowledgeable friend who always has your health in mind.
Anytime, Anywhere: Your Personal Diabetes Advisor
Accessible from smartphones, Dana is now available on Google Play and soon on the Apple App Store. The app’s features include:
  • Instant, AI-driven responses to any diabetes-related query.
  • Real-time feedback and analysis of blood sugar readings.
  • Emotional support and motivational prompts.
  • Tracking of dietary intake, medication adherence, and other health metrics.
  • Monthly personalized health summaries.
A Word from the CEO
“Our goal was to create an AI companion that could address the multifaceted nature of diabetes management,” says Dr. Shimon Zilbershlag, CEO of CureChat. “Dana is not just a technological marvel; it's a compassionate entity that understands the unique clinical and emotional challenges people with diabetes face daily. It's set to redefine how we manage chronic conditions like diabetes.”
Special Launch Promotion
Dana is offered with a one-month free trial, giving full access to all features, including unlimited monitoring and queries. Following the trial, a subscription is available for $3.99/month for enhanced services and an increased query limit.
About CureChat
CureChat is a leading tech innovator in the healthcare sector, dedicated to improving health outcomes through digital solutions. The company combines technology and empathy to create user-centric health tools, making healthcare more accessible and personalized.
For more information:
Dr. Shimon Zilbershlag
www.CureChat.co